Literature DB >> 10640162

Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.

Y F Fong1, K Singh.   

Abstract

Adenomyosis is an important cause of menorrhagia. Besides hysterectomy, the treatment options for adenomyosis have been limited. Presented here is the successful treatment of adenomyosis in a woman presenting with menorrhagia, dysmenorrhea, and an enlarging uterus, for whom conservative therapy initiated with mefenamic acid was unsatisfactory. The patient had insertion of the levonorgestrel-releasing intrauterine system (LNG-IUS). A marked decrease in uterine size occurred within 12 months of insertion accompanied by resolution of the menorrhagia and dysmenorrhea. Thus, the LNG-IUS is a viable option and represents a real advance in the treatment of adenomyosis.

Entities:  

Keywords:  Asia; Biology; Case Studies--women; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Developing Countries; Diseases; Dysmenorrhea; Family Planning; Genitalia; Genitalia, Female; Iud; Iud, Hormone Releasing; Levonorgestrel; Menorrhagia; Menstruation Disorders; Pain; Physiology; Research Methodology; Signs And Symptoms; Singapore; Southeastern Asia; Studies; Treatment; Urogenital System; Uterine Effects; Uterus; Women

Mesh:

Substances:

Year:  1999        PMID: 10640162     DOI: 10.1016/s0010-7824(99)00075-x

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  6 in total

1.  Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.

Authors:  Tiina Backman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS.

Authors:  Paula H Bednarek; Jeffrey T Jensen
Journal:  Int J Womens Health       Date:  2010-08-09

Review 3.  Myomas and Adenomyosis: Impact on Reproductive Outcome.

Authors:  Nikos F Vlahos; Theodoros D Theodoridis; George A Partsinevelos
Journal:  Biomed Res Int       Date:  2017-11-06       Impact factor: 3.411

4.  Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis.

Authors:  Peihai Zhang; Kun Song; Li Li; Kazunori Yukuwa; Beihua Kong
Journal:  Med Princ Pract       Date:  2013-06-19       Impact factor: 1.927

Review 5.  Progesterone Actions and Resistance in Gynecological Disorders.

Authors:  James A MacLean; Kanako Hayashi
Journal:  Cells       Date:  2022-02-13       Impact factor: 6.600

6.  The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability.

Authors:  Megan N Beatty; Paul D Blumenthal
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.